Ally Bridge MedAlpha Master Fund L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% |
-121,000 (-7.46%) |
Filing |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ally Bridge MedAlpha Master Fund L.P. | 1,622,591 5.100% |
1,622,591 (New Position) |
Filing |